发明名称 DERIVATIVES OF PYRROLOPYRIMIDINE, METHOD FOR PREPARING AND THEIR USING
摘要 FIELD: organic chemistry, chemical technology, medicine. ^ SUBSTANCE: invention relates to new derivatives of pyrrolopyrimidine of the formula (1) and their pharmaceutically acceptable salts possessing properties of selective inhibitor of specific cyclic guanosine 3',5'-monophosphate phosphodiesterase (specific cGMP PDE) (PDE V). In the formula (1) R1 represents hydrogen atom (H), (C1-C3)-alkyl substituted optionally with one or some fluorine atoms; R2 represents H, halogen atom, (C1-C6)-alkyl substituted optionally with hydroxyl group (-OH), (C1-C3)-alkoxy-group, (C3-C6)-cycloalkyl or one or some fluorine atoms, (C3-C6)-cycloalkyl; R3 represents (C1-C6)-alkyl substituted optionally with (C3-C6)-cycloalkyl or one or some fluorine atoms; R4 represents (C1-C6)-alkyl substituted optionally with one or some fluorine atoms; R5 represents -SO2NR6R, -NHSO2R8 or heterocyclyl such as tetrazolyl; each R6 and R7 represents independently H or (C1-C6)-alkyl substituted optionally with -CO2H or one or some fluorine atoms; or in common with nitrogen atom to which they are bound form monocylic ring, such as imidazole, pyrrolidine, piperidine, morpholine, piperazine and homopiperazine wherein indicated group is replaced optionally with R9 wherein R9 represents (C1-C6)-alkyl substituted optionally with one or some halogen atoms, hydroxyl group (OH), (C1-C3)-alkoxy-group that is replaced optionally with one or some fluorine atoms, -NR11R12, -C=NR13(NR14R15) or tetrazolyl group, 6-membered nitrogen-containing heteroaryl group; each R11 and R12 represents independently H or (C1-C4)-alkyl; R13represents H; each R14 and R15 represents independently H. Also, invention relates to intermediate compounds, methods for preparing compounds and pharmaceutical compositions. Proposed compounds can be used in treatment of impotency, sexual dysfunction in females, stable, nonstable and variant (Prinzmental) stenocardia and other diseases also. ^ EFFECT: improved preparing method, valuable medicinal properties of compounds. ^ 15 cl, 1 tbl, 250 ex
申请公布号 RU2263676(C2) 申请公布日期 2005.11.10
申请号 RU20020124872 申请日期 2001.02.15
申请人 发明人 KIM DAE-KEE;LI DZU JANG;RIU DO KHIUN;LI NAM KIU;LI SUK KHO;KIM NAM-KHO;KIM DZAE-SUN;RIU DZE KHO;CHOJ DZIN-JANG;IM GUANG-DZIN;CHOJ VON-SON;KIM TAE KON;CHA KHOON
分类号 A61K31/51;A61K31/519;A61K31/551;A61P1/04;A61P9/00;A61P9/04;A61P9/08;A61P9/10;A61P9/12;A61P11/00;A61P11/02;A61P11/06;A61P13/12;A61P15/00;A61P15/10;A61P15/14;A61P27/02;A61P29/00;A61P37/08;A61P43/00;C07D207/00;C07D207/34;C07D239/00;C07D487/04 主分类号 A61K31/51
代理机构 代理人
主权项
地址